Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice

Timothy E. Koeltzow, Ming Xu, Donald C. Cooper, Xiu Ti Hu, Susumu Tonegawa, Marina Wolf, Francis J. White

Research output: Contribution to journalArticle

191 Citations (Scopus)

Abstract

Dopamine (DA) autoreceptors expressed along the somatodendritic extent of midbrain DA neurons modulate impulse activity, whereas those expressed at DA nerve terminals regulate both DA synthesis and release. Considerable evidence has indicated that these DA autoreceptors are of the D2 subtype of DA receptors. However, many pharmacological studies have suggested an autoreceptor role for the DA D3 receptor. This possibility was tested with mice lacking the D3 receptor as a result of gene targeting. The basal firing rates of DA neurons within both the substantia nigra and ventral tegmental area were not different in D3 receptor mutant and wild-type mice. The putative D3 receptor-selective agonist R(+)-trans-3,4,4a, 10b-tetrahydro-4- propyl-2H, 5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol (PD 128907) was equipotent at inhibiting the activity of both populations of midbrain DA neurons in the two groups of mice. In the χ-butyrolactone (GBL) model of DA autoreceptor function, mutant and wild-type mice were identical with respect to striatal DA synthesis and its suppression by PD 128907. In vivo microdialysis studies of DA release in ventral striatum revealed higher basal levels of extracellular DA in mutant mice but similar inhibitory effects of PD 128907 in mutant and wildtype mice. These results suggest that the effects of PD 128907 on dopamine cell function reflect stimulation of D2 as opposed to D3 receptors. Although D3 receptors do not seem to be significantly involved in DA autoreceptor function, they may participate in postsynaptically activated short-loop feedback modulation of DA release.

Original languageEnglish (US)
Pages (from-to)2231-2238
Number of pages8
JournalJournal of Neuroscience
Volume18
Issue number6
StatePublished - Mar 15 1998
Externally publishedYes

Fingerprint

Dopamine D3 Receptors
Autoreceptors
Dopamine
Dopaminergic Neurons
Mesencephalon
Corpus Striatum
Ventral Tegmental Area
Gene Targeting
Dopamine D2 Receptors
Microdialysis
Substantia Nigra

Keywords

  • D receptors
  • Dopamine autoreceptors
  • Dopamine neurons
  • Dopamine receptors
  • Dopamine release
  • Dopamine synthesis
  • Mutant mice

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Koeltzow, T. E., Xu, M., Cooper, D. C., Hu, X. T., Tonegawa, S., Wolf, M., & White, F. J. (1998). Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. Journal of Neuroscience, 18(6), 2231-2238.

Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. / Koeltzow, Timothy E.; Xu, Ming; Cooper, Donald C.; Hu, Xiu Ti; Tonegawa, Susumu; Wolf, Marina; White, Francis J.

In: Journal of Neuroscience, Vol. 18, No. 6, 15.03.1998, p. 2231-2238.

Research output: Contribution to journalArticle

Koeltzow, TE, Xu, M, Cooper, DC, Hu, XT, Tonegawa, S, Wolf, M & White, FJ 1998, 'Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice', Journal of Neuroscience, vol. 18, no. 6, pp. 2231-2238.
Koeltzow, Timothy E. ; Xu, Ming ; Cooper, Donald C. ; Hu, Xiu Ti ; Tonegawa, Susumu ; Wolf, Marina ; White, Francis J. / Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. In: Journal of Neuroscience. 1998 ; Vol. 18, No. 6. pp. 2231-2238.
@article{a9bb53fc7ea94bdb9d230d2bba92348a,
title = "Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice",
abstract = "Dopamine (DA) autoreceptors expressed along the somatodendritic extent of midbrain DA neurons modulate impulse activity, whereas those expressed at DA nerve terminals regulate both DA synthesis and release. Considerable evidence has indicated that these DA autoreceptors are of the D2 subtype of DA receptors. However, many pharmacological studies have suggested an autoreceptor role for the DA D3 receptor. This possibility was tested with mice lacking the D3 receptor as a result of gene targeting. The basal firing rates of DA neurons within both the substantia nigra and ventral tegmental area were not different in D3 receptor mutant and wild-type mice. The putative D3 receptor-selective agonist R(+)-trans-3,4,4a, 10b-tetrahydro-4- propyl-2H, 5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol (PD 128907) was equipotent at inhibiting the activity of both populations of midbrain DA neurons in the two groups of mice. In the χ-butyrolactone (GBL) model of DA autoreceptor function, mutant and wild-type mice were identical with respect to striatal DA synthesis and its suppression by PD 128907. In vivo microdialysis studies of DA release in ventral striatum revealed higher basal levels of extracellular DA in mutant mice but similar inhibitory effects of PD 128907 in mutant and wildtype mice. These results suggest that the effects of PD 128907 on dopamine cell function reflect stimulation of D2 as opposed to D3 receptors. Although D3 receptors do not seem to be significantly involved in DA autoreceptor function, they may participate in postsynaptically activated short-loop feedback modulation of DA release.",
keywords = "D receptors, Dopamine autoreceptors, Dopamine neurons, Dopamine receptors, Dopamine release, Dopamine synthesis, Mutant mice",
author = "Koeltzow, {Timothy E.} and Ming Xu and Cooper, {Donald C.} and Hu, {Xiu Ti} and Susumu Tonegawa and Marina Wolf and White, {Francis J.}",
year = "1998",
month = "3",
day = "15",
language = "English (US)",
volume = "18",
pages = "2231--2238",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "6",

}

TY - JOUR

T1 - Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice

AU - Koeltzow, Timothy E.

AU - Xu, Ming

AU - Cooper, Donald C.

AU - Hu, Xiu Ti

AU - Tonegawa, Susumu

AU - Wolf, Marina

AU - White, Francis J.

PY - 1998/3/15

Y1 - 1998/3/15

N2 - Dopamine (DA) autoreceptors expressed along the somatodendritic extent of midbrain DA neurons modulate impulse activity, whereas those expressed at DA nerve terminals regulate both DA synthesis and release. Considerable evidence has indicated that these DA autoreceptors are of the D2 subtype of DA receptors. However, many pharmacological studies have suggested an autoreceptor role for the DA D3 receptor. This possibility was tested with mice lacking the D3 receptor as a result of gene targeting. The basal firing rates of DA neurons within both the substantia nigra and ventral tegmental area were not different in D3 receptor mutant and wild-type mice. The putative D3 receptor-selective agonist R(+)-trans-3,4,4a, 10b-tetrahydro-4- propyl-2H, 5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol (PD 128907) was equipotent at inhibiting the activity of both populations of midbrain DA neurons in the two groups of mice. In the χ-butyrolactone (GBL) model of DA autoreceptor function, mutant and wild-type mice were identical with respect to striatal DA synthesis and its suppression by PD 128907. In vivo microdialysis studies of DA release in ventral striatum revealed higher basal levels of extracellular DA in mutant mice but similar inhibitory effects of PD 128907 in mutant and wildtype mice. These results suggest that the effects of PD 128907 on dopamine cell function reflect stimulation of D2 as opposed to D3 receptors. Although D3 receptors do not seem to be significantly involved in DA autoreceptor function, they may participate in postsynaptically activated short-loop feedback modulation of DA release.

AB - Dopamine (DA) autoreceptors expressed along the somatodendritic extent of midbrain DA neurons modulate impulse activity, whereas those expressed at DA nerve terminals regulate both DA synthesis and release. Considerable evidence has indicated that these DA autoreceptors are of the D2 subtype of DA receptors. However, many pharmacological studies have suggested an autoreceptor role for the DA D3 receptor. This possibility was tested with mice lacking the D3 receptor as a result of gene targeting. The basal firing rates of DA neurons within both the substantia nigra and ventral tegmental area were not different in D3 receptor mutant and wild-type mice. The putative D3 receptor-selective agonist R(+)-trans-3,4,4a, 10b-tetrahydro-4- propyl-2H, 5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol (PD 128907) was equipotent at inhibiting the activity of both populations of midbrain DA neurons in the two groups of mice. In the χ-butyrolactone (GBL) model of DA autoreceptor function, mutant and wild-type mice were identical with respect to striatal DA synthesis and its suppression by PD 128907. In vivo microdialysis studies of DA release in ventral striatum revealed higher basal levels of extracellular DA in mutant mice but similar inhibitory effects of PD 128907 in mutant and wildtype mice. These results suggest that the effects of PD 128907 on dopamine cell function reflect stimulation of D2 as opposed to D3 receptors. Although D3 receptors do not seem to be significantly involved in DA autoreceptor function, they may participate in postsynaptically activated short-loop feedback modulation of DA release.

KW - D receptors

KW - Dopamine autoreceptors

KW - Dopamine neurons

KW - Dopamine receptors

KW - Dopamine release

KW - Dopamine synthesis

KW - Mutant mice

UR - http://www.scopus.com/inward/record.url?scp=0032520839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032520839&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 2231

EP - 2238

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 6

ER -